Novavax’s COVID-19 vaccine 96.4 per cent effective against virus in phase-3 trial
New York: US-based biotech company Novavax's COVID-19 vaccine was 96.4 per cent effective against original strain of the virus in ...
Read more
New York: US-based biotech company Novavax's COVID-19 vaccine was 96.4 per cent effective against original strain of the virus in ...
Read more
The Central Vista project is finally picking up steam, with a buzz around relocating key government ministries to swanky, high-tech...
Read more
It would be wrong for the BJP-led NDA government to dismiss as the Opposition’s disruptive tactic the furore in the...
Read more
The shadow of Donald Trump, with trade and economic uncertainties linked to his return to the White House in January...
Read more
I n what appears to be a pro-incumbency mandate, the Mahayuti coalition led by the BJP swept the Maharashtra Assembly...
Read more